Vitamin D May Reduce Immune Checkpoint Inhibitor–Related Colitis
Vitamin D may be used to reduce the risk of immune checkpoint inhibitor-related colitis, as well as ulcerative colitis and graft-vs-host disease.
Oncology
US Medical Cancer Care Costs Substantial, Expected to Increase
Costs of care for patients with cancer was found to vary based on stage and site of disease.
Racial Disparities Seen in PET/CT Imaging for Lung Cancer
Black and Hispanic patients are less likely to undergo guideline-recommended imaging at diagnosis of non-small cell lung cancer.
African-American Participation Inadequate in Cancer Drug Trials
African-Americans are underrepresented in clinical trials leading to approval of cancer medications.
Higher Levels of Outdoor Light at Night May Be Linked to Increased Breast Cancer Risk
The incidence of breast cancer for postmenopausal women included in the NIH-AARP study was evaluated with respect to level of outdoor light at night.
Artificial Intelligence in Cancer: How Is It Used in Practice?
This fact sheet describes how artificial intelligence is currently being used in oncology.
Eligibility Criteria a Significant Barrier to Patient Enrollment in Oncology Clinical Trials
Review of responses to clinical trial prompts within an oncology clinical pathways system identified barriers to increasing patient enrollment in clinical trials.
Assessing Goals of Care to Ensure End-of-Life Care Follows Patients’ Wishes
A single-item visual analog scale has been shown to ensure that oncologists’ perceptions and patients’ wishes for end of life care are in agreement.
Practice-Level Factors Influence Oncologists’ Likelihood of Discussing Genomic Testing Costs With Patients
Approximately half of oncologists discuss genomic testing with their patients, and several practice-level factors influence oncologists’ likelihood of discussing the associated costs, a study in the Journal of the National Cancer Institute reports.
Race Reporting and Representation Remain Disparate in Pivotal Cancer Trials
Researchers evaluated the frequency of race reporting and race representation in pivotal drug trials that are used to establish standards of care in oncology treatment.
-
Loading...
-
Loading...
Next post in Medicine
